Conference Call on Thursday, March 15, 4:30 p.m. (ET)
RICHMOND, VA., March 9 /CNW/ - Insmed (NASDAQ: INSM) today announced that
it will release its 2006 fourth quarter and year end financial results after
market close on Wednesday, March 14, 2007.
Management will host an investment community conference call beginning at
4:30 p.m. Eastern Time, on Thursday March 15, at 4:30 p.m. (ET) to discuss the
financial results, provide a business update and answer questions.
Individuals interested in listening to the live conference call may do so
by dialing (877)407-0782 toll free within the U.S. and Canada, or (201)
689-8567 for international callers.
A telephone replay will be available approximately two hours after the
call for two weeks by dialing (877) 660-6853 from the U.S., or (201) 612-7415
for international callers. The account code is 286; the conference number is
Individuals interested in listening to the conference call via the
Internet may do so by visiting www.insmed.com. A replay will be available on
the Company's Web site for 90 days.
Insmed Inc. is a biopharmaceutical company focused on the development and
commercialization of drug candidates for the treatment of metabolic diseases
and endocrine disorders with unmet medical needs. For more information, please
Insmed Safe Harbor Statement
Statements included within this press release, which are not historical
in nature, may constitute forward-looking statements for purposes of the safe
harbor provided by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements in this press release include, but are not limited
to, statements regarding business strategies, growth opportunities for
approved or proposed products, plans and objectives of management. Such
forward-looking statements are subject to numerous risks and uncertainties,
including risks that our product candidates may fail in clinical trials or may
not be successfully marketed, we may lack financial resources to complete
development of product candidates, we may be unable to raise additional
financing necessary to continue current operations competing products may be
more successful, demand for new pharmaceutical products may decrease and the
biopharmaceutical industry may experience negative market trends. As a result
of these and other risks and uncertainties, actual results may differ
materially from those described in this press release. For further information
with respect to factors that could cause actual results to differ from
expectations, reference is made to reports filed by the Company with the
Securities and Exchange Commission under the Securities Exchange Act of 1934,
as amended. The forward-looking statements made in this release are made only
as of the date hereof and Insmed disclaims any intention or responsibility for
updating predictions or financial guidance contained in this release.
For further information:
For further information: Insmed Incorporated Jody M. Lomenzo,
804-565-3041 Director, Investor Relations & Corporate Communications